Biventricular Versus Right Ventricular Pacing
Key facts
- Who runs it
- Indiana University
- Where
- Indianapolis, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 1 person enrolled
- Started
- 9 Aug 2023
- Ended
- 10 Nov 2023
- Type of study
- Interventional, 2 groups
- Treatments tested
- Biventricular Pacing
- Right Ventricular Pacing
- Record updated
- 10 December 2024
- Why it stopped
- Coordinator support was lost
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Patients with both an LVAD and CRT device with functional leads
- Age 18 years and older
- Ability to walk
- Ability to sign consent
Who cannot take part
- Patients with permanent atrial fibrillation
- Patients who are pacemaker dependent
- Patients with sustained ventricular tachycardia
Where in United States
- Indiana University Health Methodist HospitalIndianapolis, United States
About the trial
What the trial wants to find out
The study is a randomized, single-blind crossover prospective study in which investigators will determine the clinical outcomes of cardiac resynchronization therapy (CRT) pacing modalities in patients with left ventricular assist devices (LVAD). Only patients are blinded. This is a small-scale study from which future larger scale randomized controls can be performed. The primary endpoint will be the effect of BiV and RV pacing setting on the 6-minute walk test.
The 2 groups in the trial
- Biventricular Pacing followed by Right Ventricular PacingTreatment being tested
Subjects will be randomly assigned to the order of pacing interventions. After baseline testing (with their CRT device still in the subjects' baseline pacing modality), subjects assigned to BiV-first will have their CRT device reprogrammed to BiV pacing modality in the clinic. After undergoing three months of treatment in this pacing modality, they will return to clinic for retesting. The CRT device will then be reprogrammed to RV pacing for the next 3 months. Subjects will then again return to clinic for retesting, and their CRT device will be reprogrammed to their baseline pacing modality.
Treatment: Biventricular Pacing and Right Ventricular Pacing
- Right Ventricular Pacing followed by Biventricular PacingTreatment being tested
Subjects will be randomly assigned to the order of pacing interventions. After baseline testing (with their CRT device still in the subjects' baseline pacing modality), subjects assigned to RV-first will have their CRT device reprogrammed to RV pacing modality in the clinic. After undergoing three months of treatment in this pacing modality, they will return to clinic for retesting. The CRT device will then be reprogrammed to BiV pacing for the next 3 months. Subjects will then again return to clinic for retesting, and their CRT device will be reprogrammed to their baseline pacing modality.
Treatment: Biventricular Pacing
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Selection of Cardiac Resynchronization Therapy Pacing Modalities in Patients Supported by LVADs
- Record updated
- 10 December 2024